Observational studyBMC anesthesiology2025
Clevidipine versus nitroglycerin for blood pressure control during carotid endarterectomy: a cohort study.
Observational study in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClevidipine is an ultrafast-acting dihydropyridine calcium channel antagonist with selective arteriolar-dilating effects that may be suitable for afterload reduction during surgeries requiring tight blood pressure control. The objective of this single-center retrospective observational study was to evaluate the role of clevidipine to control blood pressure during carotid endarterectomy.
methodsPatients undergoing elective carotid endarterectomy from October 2024 to March 2025 who received clevidipine or nitroglycerin for intraoperative blood pressure management were included. The primary endpoint was the area under the curve of systolic blood pressure excursions outside the predefined target range of 140-160 mmHg. Secondary outcomes included corresponding measurements for mean arterial pressure and heart rate, as well as the incidence of significant clinical complications.
resultsOf 40 included patients, 20 received clevidipine and 20 received nitroglycerin. Patients in the clevidipine group spent significantly less time outside the goal systolic blood pressure range than the nitroglycerin group (10 min vs. 37.5 min, p < 0.001). The median normalized area under the curve per five-minute intervals was 29.59 mmHg × min (interquartile range, 15.83 to 49.35) in the clevidipine group versus 60.30 mmHg × min (interquartile range 42.79 to 74.38) in the nitroglycerin group (p = 0.005). There were no significant differences in mean arterial pressure, heart rate, or clinical complications between the groups.
conclusionsClevidipine was associated with significantly fewer blood pressure excursions outside the target goal range compared to nitroglycerin during carotid endarterectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.